Silvercrest Asset Management Group LLC Atri Cure, Inc. Transaction History

Silvercrest Asset Management Group LLC

$14.1 Billion
Q1 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 190,550 shares of ATRC stock, worth $4.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

190,550

Previous 257,865 26.1%

Holding current value

$4.34 Million

Previous $9.2 Million 37.02%

% of portfolio

0.04%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $1.9 Million - $2.54 Million	-67,315 Reduced 26.1%	190,550 $5.8 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $1.82 Million - $2.38 Million	55,115 Added 27.18%	257,865 $9.2 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $2 Million - $2.81 Million	-48,636 Reduced 19.35%	202,750 $8.88 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $1.52 Million - $1.86 Million	37,506 Added 17.54%	251,386 $12.4 Million
Q1 2023 May 15, 2023	SELL	$35.87 - $47.22 $6,600 - $8,688	-184 Reduced 0.09%	213,880 $8.87 Million

Q4 2022 Feb 14, 2023	SELL	$33.48 - $47.45 $109,345 - $154,971	-3,266 Reduced 1.5%	214,064 $9.5 Million
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $206,091 - $283,516	-5,388 Reduced 2.42%	217,330 $8.5 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $2.53 Million - $4.77 Million	72,191 Added 47.96%	222,718 $9.1 Million
Q1 2022 May 16, 2022	BUY	$57.43 - $71.39 $101,823 - $126,574	1,773 Added 1.19%	150,527 $9.89 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $47,867 - $65,790	755 Added 0.51%	148,754 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $227,307 - $277,113	-3,281 Reduced 2.17%	147,999 $10.3 Million
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $2.82 Million - $3.53 Million	-44,050 Reduced 22.55%	151,280 $12 Million
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $1.42 Million - $1.77 Million	-26,402 Reduced 11.91%	195,330 $12.8 Million
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $209,675 - $349,155	6,067 Added 2.81%	221,732 $12.3 Million
Q3 2020 Nov 16, 2020	BUY	$38.36 - $46.91 $1.72 Million - $2.1 Million	44,720 Added 26.16%	215,665 $8.61 Million
Q2 2020 Aug 14, 2020	SELL	$31.78 - $51.19 $1.42 Million - $2.29 Million	-44,831 Reduced 20.78%	170,945 $7.68 Million
Q1 2020 May 15, 2020	SELL	$24.49 - $43.84 $935,346 - $1.67 Million	-38,193 Reduced 15.04%	215,776 $7.25 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $1.61 Million - $2.17 Million	-66,743 Reduced 20.81%	253,969 $8.26 Million
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $7.64 Million - $10.4 Million	320,712 New	320,712 $8 Million

Others Institutions Holding ATRC

# of Institutions

237

Shares Held

46.7M

Call Options Held

95.7K

Put Options Held

119K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.06B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Atri Cure, Inc. Transaction History